NCT02062099View on ClinicalTrials.gov

PET Imaging of the Translocator Proteine Ligands (TSPO) With [18 F] DPA-714 Biomarker of NeuroInflammation in Cognitive Decline (NIDECO)

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

May 22, 2018

Study Completion Date

May 22, 2018

Conditions
Memory ComplaintMild Cognitive ImpairmentAlzheimer Disease
Interventions
DRUG

[18F]DPA-714 PET/ [18F]AV-45 PET/neuropsychological assessment

Trial Locations (1)

37000

University Hospital of Tours, Tours

All Listed Sponsors
lead

University Hospital, Tours

OTHER

NCT02062099 - PET Imaging of the Translocator Proteine Ligands (TSPO) With [18 F] DPA-714 Biomarker of NeuroInflammation in Cognitive Decline (NIDECO) | Biotech Hunter | Biotech Hunter